Combination therapy using azabicyclo compound for cancer Grant US-11918562-B2 United States of America 05 Mar 2024
Combination therapies comprising targeted therapeutics Grant US-11491145-B2 United States of America 08 Nov 2022
Combination therapy using azabicyclo compound for cancer Grant US-11166943-B2 United States of America 09 Nov 2021
Combination therapy using azabicyclo compound for cancer Grant US-10849886-B2 United States of America 01 Dec 2020
Combination therapy of HSP90 inhibitors with platinum-containing agents Grant US-10500193-B2 United States of America 10 Dec 2019
Combination therapy using azabicyclo compound for cancer Grant US-9694001-B2 United States of America 04 Jul 2017
Cancer therapy using a combination of HSP90 inhibitors with topoisomerase I inhibitors Grant US-9439899-B2 United States of America 13 Sep 2016
Combination therapy of HSP90 inhibitors with BRAF inhibitors Grant US-9402831-B2 United States of America 02 Aug 2016
Cancer therapy using a combination of a Hsp90 inhibitory compounds and a EGFR inhibitor Grant US-9205086-B2 United States of America 08 Dec 2015
SPECIFIC CANCER TREATMENT REGIMENS WITH GANETESPIB Application WO-2014189937-A1 World Intellectual Property Organisation (WIPO) 27 Nov 2014
PRE-SELECTION OF SUBJECTS FOR THERAPEUTIC TREATMENT WITH AN HSP90 INHIBITOR BASED ON… Application WO-2013173436-A1 World Intellectual Property Organisation (WIPO) 21 Nov 2013
TREATING CANCER WITH AN HSP90 INHIBITORY COMPOUND Application WO-2013170182-A1 World Intellectual Property Organisation (WIPO) 14 Nov 2013